Li Tsai-Chung, Kardia Sharon L R, Li Chia-Ing, Chen Ching-Chu, Liu Chiu-Shong, Yang Sing-Yu, Muo Chin-Shin, Peyser Patricia A, Lin Cheng-Chieh
Graduate Institute of Biostatistics, College of Public Health, China Medical University, Taichung, Taiwan; Department of Healthcare Administration, College of Health Science, Asia University, Taichung, Taiwan.
Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan; Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.
Metabolism. 2015 Sep;64(9):1013-21. doi: 10.1016/j.metabol.2015.05.004. Epub 2015 May 10.
The relationship between glycemic control and adverse outcomes found in a population with diabetes has seldom been evaluated in patients with type 2 diabetes. We explored the association between hemoglobin A1c (HbA1c) and hospitalization risks within one-year and eight-year follow-up periods.
We conducted a retrospective cohort study on 57,061 patients with type 2 diabetes from National Diabetes Case Management Program during 2002-2004 in Taiwan. HbA1c at baseline and in-hospital mortality, all-cause and cause-specific hospitalization over one year and eight years were analyzed.
After multivariate adjustment, one-year risk was higher for cases with HbA1c level <6%, 9-10%, ≥10% versus 6-7% for all-cause hospitalization (hazard ratio [HR]: 1.11, 95% confidence interval [CI]: 1.03-1.20; 1.08, 1.01-1.16, and 1.19, 1.12-1.26, respectively) and for ≥10% for diabetes-related hospitalization (1.68, 1.46-1.92). Yet each 1-step increment in HbA1c category (<6.0, 6.0-6.9, 7.0-7.9, 8.0-8.9, 9.0-9.9 and ≥10.0%) showed linkage with lower risk of hypoglycemia hospitalization (0.81, 95% CI: 0.74-0.88). For eight-year risk, subjects with HbA1c level <6%, and ≥10% were more likely to have in-hospitality mortality (1.16, 1.03-1.31, and 1.23, 1.11-1.35, respectively). Each 1-step increment in HbA1c category showed an association with higher risks of all-cause and diabetes-related hospitalization (1.04, 1.03-1.05, and 1.15, 1.14-1.17, respectively).
Higher HbA1c level correlated with lower one-year risk due to hypoglycemia hospitalization but increased one-year and eight-year risks due to all-cause and diabetes-specific hospitalization among Chinese people with type 2 diabetes in Taiwan. Future study must ascertain how to meet HbA1c targets and improve outcome without risk to this population.
糖尿病患者人群中血糖控制与不良结局之间的关系在2型糖尿病患者中很少得到评估。我们探讨了糖化血红蛋白(HbA1c)与1年和8年随访期内住院风险之间的关联。
我们对2002 - 2004年台湾地区国家糖尿病病例管理项目中的57061例2型糖尿病患者进行了一项回顾性队列研究。分析了基线时的HbA1c以及1年和8年内的院内死亡率、全因住院率和特定病因住院率。
多变量调整后,HbA1c水平<6%、9 - 10%、≥10%的患者与HbA1c水平在6 - 7%的患者相比,全因住院的1年风险更高(风险比[HR]:分别为1.11,95%置信区间[CI]:1.03 - 1.20;1.08,1.01 - 1.16;1.19,1.12 - 1.26),糖尿病相关住院≥10%的患者风险更高(1.68,1.46 - 1.92)。然而,HbA1c类别每增加1步(<6.0、6.0 - 6.9、7.0 - 7.9、8.0 - 8.9、9.0 - 9.9和≥10.0%)与低血糖住院风险降低相关(0.81,95% CI:0.74 - 0.88)。对于8年风险,HbA1c水平<6%和≥10%的受试者更有可能发生院内死亡(分别为1.16,1.03 - 1.31和1.23,1.11 - 1.35)。HbA1c类别每增加1步与全因住院和糖尿病相关住院风险增加相关(分别为1.04,1.03 - 1.05和1.15,1.14 - 1.17)。
较高的HbA1c水平与台湾地区2型糖尿病中国人因低血糖住院的1年风险较低相关,但与全因住院和糖尿病特异性住院的1年及8年风险增加相关。未来的研究必须确定如何在不使该人群面临风险的情况下达到HbA1c目标并改善结局。